tag:blogger.com,1999:blog-87242135394486145322024-03-19T16:41:48.157-04:00Biomedical Sciences BlogThis is a site to promote education and career development in biotechnology and biomedical related fields.
To support our efforts, please go shopping through one of our sponsor links or search box. We will earn a sales commission on each transaction you initiate through our web site -- and it won't cost you a penny more!Unknownnoreply@blogger.comBlogger430125tag:blogger.com,1999:blog-8724213539448614532.post-83163178333165307192013-06-23T22:35:00.002-04:002013-06-23T22:35:13.247-04:002013 New Journal Impact Factors Released!
Abbreviated
Journal Title
ISSN
2012
Impact
Total Cites
Factor
CA-CANCER J CLIN
0007-9235
13722
153.459
NEW ENGL J MED
0028-4793
245605
51.658
REV MOD PHYS
0034-6861
35720
44.982
CHEM REV
0009-2665
112596
41.298
NAT REV GENET
1471-0056
23358
41.063
LANCET
0140-6736
166922
39.06
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-53500153670067992182013-06-23T22:34:00.000-04:002013-06-23T22:34:09.192-04:00
Abbreviated
Journal Title
ISSN
2012
Impact
Total Cites
Factor
CA-CANCER J CLIN
0007-9235
13722
153.459
NEW ENGL J MED
0028-4793
245605
51.658
REV MOD PHYS
0034-6861
35720
44.982
CHEM REV
0009-2665
112596
41.298
NAT REV GENET
1471-0056
23358
41.063
LANCET
0140-6736
166922
39.06
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-2017909098532482642013-06-23T21:03:00.000-04:002013-06-23T21:03:25.457-04:002013 Journal Impact Factor Released!
Abbreviated
Journal Title
ISSN
2012
Impact
Total Cites
Factor
CA-CANCER J CLIN
0007-9235
13722
153.459
NEW ENGL J MED
0028-4793
245605
51.658
REV MOD PHYS
0034-6861
35720
44.982
CHEM REV
0009-2665
112596
41.298
NAT REV GENET
1471-0056
23358
41.063
LANCET
0140-6736
166922
39.06
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-43031521294629417332013-03-17T13:19:00.002-04:002013-03-17T13:20:12.099-04:00NIH to spend $1.5 million to study why 75 percent of lesbians are obese
The National Institutes of Health (NIH) is spending $1.5 million to
study the “high public-health significance” of why 75 percent of lesbian
women are obese and gay men are not, according to a report in The Washington Times.
“Obesity is one of the most critical public health issues affecting
the U.S. today,” the description of the grant — administered by NIH’s
Eunice Kennedy Shriver Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-26065145155815763692013-02-18T19:59:00.001-05:002013-02-18T20:01:50.262-05:00Obama to Announce 10-Year Human Brain Mapping Project
The Obama administration is planning a decade-long scientific effort to
examine the workings of the human brain and build a comprehensive map of
its activity, seeking to do for the brain what the Human Genome Project did for genetics.
The project, which the administration has been looking to unveil as
early as March, will include federal agencies, private foundations and
teams of Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-56909996397489272112013-01-06T21:55:00.002-05:002013-01-06T21:56:40.633-05:00Research Investigator, Stiefel (a GSK Company), RTP NC
The
purpose of this position is to provide cell biology, molecular biology,
pharmacology, expertise and support for the design, execution,
monitoring, data review, and reports preparation related to
translational
and preclinical research in the acne care area.
Responsibilities:
Providing key cell biology, and molecular biology support for Stiefel acne research programs:
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-20741595138916751392013-01-06T21:54:00.003-05:002013-01-06T21:57:18.769-05:002013 AACCI Translational Cancer Research Fellowship
Applications
are now being accepted for the 2013 Association of American Cancer
Institutes (AACI) Translational Cancer Research Fellowship. This
$50,000 one-year non-renewable grant will support postdoctoral
training to individuals who have completed at least one year of training
in any field of oncology and have at least one year of training
remaining at an AACI member institution. Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-14993098851475758062013-01-06T21:53:00.002-05:002013-01-06T21:53:31.549-05:00US Census Bureau Postdoctoral Research Program
Postdoctoral Research Program
The Census Bureau’s mission is to be the preeminent collector and
provider of timely, relevant, and quality data about the people and
economy of the United States. Over 200 years ago, the United States
Constitution laid the foundation for what is today the world’s largest
and most comprehensive data gathering organization. The Census Bureau
was founded in 1902.Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-64498235625486383582012-12-04T21:27:00.003-05:002012-12-04T21:27:45.631-05:00China tests system to grow vegetables, harvest oxygen on MarsChinese astronauts are preparing
plans to grow fresh vegetables on Mars and the moon after researchers
successfully completed a preliminary test in Beijing.
Four
kinds of vegetables were grown in an 'ecological life support system', a
300 cubic metre cabin which will allow astronauts to develop their own
stocks of air, water and food while on space missions, Xinhua news
agency said.
The
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-85613738092100276992012-09-10T21:28:00.002-04:002012-09-10T21:31:40.333-04:00 U.S. Pushes For More Scientists, But The Jobs Aren’t There
Michelle Amaral wanted to be a brain scientist to help cure diseases.
She planned a traditional academic science career: PhD, university
professorship and, eventually, her own lab.
But three years after earning a doctorate in neuroscience, she gave up trying to find a permanent job in her field.
Dropping her dream, she took an administrative position at her
university, experiencing Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-84612175342708932262012-09-02T00:03:00.001-04:002012-09-02T00:06:48.871-04:00NIH Principal Investigators Are Getting Old
Just saw this striking video on the change in age distribution of National Institutes of Health Principal Investigators.
It is quite clear how much the distribution has shifted to the right
over the past thirty years, and that a gap has opened up between young
faculty entering the profession (illustrated through medical school
data) and the typical age of receiving a grant.
Sally Rockey,Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-1169623046060447632012-08-11T01:27:00.003-04:002012-08-11T01:28:28.951-04:00eLife Announces Board of Reviewing Editors
eLife, the new funder–researcher collaboration and forthcoming
journal for the best in life and biomedical science, has announced the
reviewing editors who will help deliver on its promise of an editorial
process to better serve science and scientists.
First announced in summer 2011, eLife is a researcher-led initiative
for the very best in science and science communication. Backed Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-8724213539448614532.post-11685484939045781372012-08-06T21:50:00.001-04:002012-08-06T21:51:58.837-04:00Astellas to Close Urogenix, North Carolina-based Urology Research FacilityTokyo, August 6, 2012 - Astellas Pharma Inc. (“Astellas”; Tokyo:4503; President and CEO: Yoshihiko Hatanaka) announced that it decided to close Urogenix, Inc. (“Urogenix”, Durham, NC, President: Shuuichi Tawara), an Astellas subsidiary, which is a research facility focusing on drug discovery in the field of urology. The closure will be completed by the end of December 2012. Urogenix currently Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-27086160057094915832012-07-26T21:40:00.000-04:002012-07-26T21:40:16.318-04:00Job Squeeze Vexes PostdocsEvery six months, Cara Altimus, Ph.D., asks herself: Am I making
progress? Is what I’m doing relevant? Am I likely to get a job one day?
Eighteen months into a five-year postdoctoral position in the lab of
David Foster, Ph.D., assistant professor of neuroscience at Johns
Hopkins University School of Medicine, Dr. Altimus has reason for
concern. Postdocs are finding it harder to land Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-8724213539448614532.post-23944816143235799272012-07-26T21:28:00.002-04:002012-07-26T21:34:04.223-04:00Record number of journals banned for boosting impact factor with self-citations29 Jun 2012
More research journals than ever are boosting their impact factors by self-citation.
Every year, Thomson Reuters, the firm that publishes the
impact-factor rankings, takes action against the most extreme offenders
by banning them from the latest lists. It lets them in again, suitably chastened, a couple of years later.
And this year, the apparent game playing has reached Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-90458488799031085122012-07-18T23:35:00.002-04:002012-07-18T23:35:57.722-04:00Impact Factors for journals published by Nature Publishing Group2011 Impact Factors – released June 2012
At NPG we are committed to serving the needs of scientists and
their science. We do this best by selecting and communicating the most
important and valuable scientific information to the broadest possible
audience. The 2011 Impact Factors reflect NPG’s success at doing this,
and the exceptional authors and referees that we are privileged to work
Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-8724213539448614532.post-6377603818274565702012-07-12T20:02:00.000-04:002012-07-12T20:03:17.370-04:00Three Years After Merger, Genentech R&D Outshines That of Roche’sThree years on, however, the jeans-wearing
scientists in San Francisco have proven they are the ones driving the
drugs pipeline of the 116-year-old Basel-based pharma giant, casting a
shadow over Roche's own research operations.
Roche's four top-selling medicines in 2011 -
Rituxan, Avastin, Herceptin and Lucentis - were all cooked up in
Genentech's labs and accounted for 55 percent of totalUnknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-36588611186482944582012-07-03T18:55:00.004-04:002012-07-03T18:57:10.158-04:00Roche to Cut Jobs, Close R&D CenterSwiss drug giant Roche Holding AG
said it would close a research site in New Jersey, resulting in the
loss of about 1,000 jobs, in another sign that the industry is cutting
investment in labs that haven't produced enough new drugs.
Roche,
based in Basel, Switzerland, said it would close a site in Nutley,
N.J., that has focused on early stage drug research for cancer and
inflammatory andUnknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-67526396087903694062012-07-03T00:27:00.002-04:002012-07-03T00:27:41.304-04:00Glaxo Agrees to Pay $3 Billion in Fraud SettlementIn the largest settlement involving a pharmaceutical company, the British drugmaker GlaxoSmithKline
agreed to plead guilty to criminal charges and pay $3 billion in fines
for promoting its best-selling antidepressants for unapproved uses and
failing to report safety data about a top diabetes drug, federal
prosecutors announced Monday. The agreement also includes civil
penalties for improper Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-34290419009860570242012-06-30T14:11:00.001-04:002012-07-15T22:53:32.343-04:00The 2012 Journal Impact Factors Released!
Philadelphia, PA, June 28, 2012-
The Intellectual Property & Science division of Thomson Reuters,
the world's leading source of intelligent information for businesses and
professionals, today announced the release of the 2011 Journal Citation ReportsR (JCR), the
world's most influential resource for information on highly cited,
peer-reviewed publications and the source of annual Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-8724213539448614532.post-59237868151338296572012-06-30T14:03:00.000-04:002012-06-30T14:03:54.474-04:00Journal Impact FactorsJournal Impact FactorsJournal Impact Factor is from Journal Citation Report (JCR), a
product of Thomson ISI (Institute for Scientific Information). JCR provides
quantitative tools for evaluating
journals. The impact factor is one of these; it is a measure of the frequency
with which the "average article" in a journal has been cited in a
given period of time.
The impact factor for a Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-54739669773524765352012-06-19T23:55:00.002-04:002012-06-19T23:55:27.724-04:00A Decade In Drug Industry LayoffsBy Matthew Herper
Since 2000, the pharmaceutical industry has cut 297,650 jobs,
according to consulting firm Challenger, Gray & Christmas. For
reference, that is about as many people as currently work at the three
largest drug makers — Pfizer, Merck, and GlaxoSmithKline — combined.
Of course, not all those people remained unemployed, and the total
headcount of the pharmaceutical Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-67119546112140691282012-03-03T23:31:00.000-05:002012-03-03T23:36:17.665-05:00New NIH Database Brings Clarity to Genetic Tests Hoping to clear up confusion about the growing welter of genetic tests, the National Institutes of Health (NIH) today unveiled a new database that lists thousands of tests voluntarily submitted by companies and non-profit labs. Genetic tests now exist for some 2500 diseases, from cystic Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-8724213539448614532.post-69525840330138494732012-03-03T23:30:00.000-05:002012-03-03T23:31:13.588-05:00U.S. to Boost Alzheimer’s Research Funding by $50 Million Feb. 7 (Bloomberg) -- The Obama administration is boosting funding for Alzheimer’s research by $50 million this year to further investigate the genetic underpinnings of the disease and test drugs that may arrest its development. About 5.1 million Americans suffer from the condition and caseloads are expected to double by 2050, according to the U.S. Department of Health and Human Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-8724213539448614532.post-55931138649892086822012-01-25T22:14:00.003-05:002012-01-25T22:27:58.735-05:00NIH Examines What Drove Its Grant Success Rate to a Record LowLast week, the National Institutes of Health (NIH) announced that the success rate for research grants, a closely watched indicator of how well investigators are doing in the struggle for funds, fell to an all-time low in 2011: 18%. At first glance, the drop appears to be due to increased competition, reflected in a steep rise on applications last year. But several other factors are also at play,Unknownnoreply@blogger.com0